(Q40839644)

24 September 2017

title

Serum interleukin-2 receptor for the early diagnosis of rheumatoid arthritis (English)

1 reference

24 September 2017

0 references

Suenaga Y

1

1 reference

24 September 2017

Yasuda M

2

1 reference

24 September 2017

Yamamoto M

3

1 reference

24 September 2017

Nonaka S

4

1 reference

24 September 2017

Wada T

5

1 reference

24 September 2017

Shiokawa S

6

1 reference

24 September 2017

Nobunaga M

7

1 reference

24 September 2017

publication date

1 January 1998

1 reference

24 September 2017

published in

Clinical Rheumatology

1 reference

24 September 2017

volume

17

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

311-317

1 reference

Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.

24 September 2017

cites work

1 reference

12 December 2020

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation

1 reference

12 December 2020

The soluble interleukin-2 receptor: biology, function, and clinical application

1 reference

12 December 2020

Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.

1 reference

12 December 2020

Antikeratin antibodies: diagnostic and prognostic markers for early rheumatoid arthritis

1 reference

12 December 2020

Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs

1 reference

12 December 2020

1958 Revision of diagnostic criteria for rheumatoid arthritis

1 reference

12 December 2020

Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate

1 reference

12 December 2020

Serial soluble interleukin 2 receptor levels in rheumatoid arthritis: differences in response to glucocorticoid treatment and chrysotherapy

1 reference

12 December 2020

Therapeutic criteria in rheumatoid arthritis

1 reference

12 December 2020

Inverting the therapeutic pyramid: observations and recommendations on new directions in rheumatoid arthritis therapy based on the author's experience.

1 reference

12 December 2020

HLA-DR antigens, Gm allotypes and antiallotypes in early rheumatoid arthritis--their relation to disease progression

1 reference

12 December 2020

Does Drug Therapy Slow Radiographic Deterioration in Rheumatoid Arthritis?

1 reference

12 December 2020

A prospective five-year comparison of treatment which included penicillamine with that excluding penicillamine in early rheumatoid arthritis. The Multicentre Trial Group

1 reference

12 December 2020

Which traditional measures should be used in rheumatoid arthritis clinical trials?

1 reference

12 December 2020

Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis

1 reference

12 December 2020

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

12 December 2020

Effect of Gold on Progression of Erosions in Rheumatoid Arthritis: Better Results with Early Treatment

1 reference

12 December 2020

Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition

1 reference

12 December 2020

Radiographic changes in early rheumatoid disease

1 reference

12 December 2020

Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis

1 reference

12 December 2020

Transient rheumatoid factor positivity in acute human parvovirus B19 infection

1 reference

12 December 2020

A Controlled Trial of Cyclophosphamide in Rheumatoid Arthritis

1 reference

12 December 2020

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis

1 reference

12 December 2020

Sulfasalazine in early rheumatoid arthritis. The Australian Multicentre Clinical Trial Group

1 reference

12 December 2020

How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?

1 reference

12 December 2020

Specificity of antibodies to type II collagen in rheumatoid arthritis

1 reference

12 December 2020

Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01451012

1 reference

24 September 2017

1 reference